Session » Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster I
- 10:30AM-12:30PM
-
Abstract Number: 0266
Analysis of Gout Remission Definitions in a Randomised Controlled Trial of Colchicine Prophylaxis for People with Gout Initiating Allopurinol
- 10:30AM-12:30PM
-
Abstract Number: 0273
Barriers and Facilitators for Outpatient Follow-Up After an Acute Gout Flare: A Qualitative Research Study
- 10:30AM-12:30PM
-
Abstract Number: 0272
Calcifications of the Transverse Ligament of the Atlas in Patients Diagnosed with Calciumpyrophosphate Crystal Arthritis – a Retrospective Observational Study
- 10:30AM-12:30PM
-
Abstract Number: 0274
Cost-effectiveness of Low Dose Colchicine Prophylaxis When Starting Allopurinol Using the “Start-Low Go-Slow” Approach for Gout
- 10:30AM-12:30PM
-
Abstract Number: 0269
Delphi Survey to Establish Consensus on the OMERACT Core Domain Set for Long-Term Studies of Calcium Pyrophosphate Deposition Disease
- 10:30AM-12:30PM
-
Abstract Number: 0278
Efficacy and Safety of Genakumab versus Compound Betamethasone in Gout: The GUARD-1 Study
- 10:30AM-12:30PM
-
Abstract Number: 0282
Electronic Health Record-Based Calcium Pyrophosphate Deposition Disease Registry: A Feasibility Study
- 10:30AM-12:30PM
-
Abstract Number: 0276
Exploring the Prevalence of Crowned Dens Syndrome in a Polymyalgia Rheumatica Veterans Affairs Patient Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0284
Identification of Calcium Pyrophosphate Deposition Using Ultrasonography in Patients with a Suspected Diagnosis of Seronegative Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0267
IL-17 Participates in the Pathogenesis of Chronic Gouty Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0271
Intercritical Gout Represents a Systemic Inflammatory State
- 10:30AM-12:30PM
-
Abstract Number: 0281
Intra-articular Treatment Combining Sustained Release Colchicine Encapsulated in Microspheres, and Ropivacaine, Is Effective in Inflammatory Arthritis in Rats
- 10:30AM-12:30PM
-
Abstract Number: 0270
Longitudinal Patterns of C-Reactive Protein Values in Calcium Pyrophosphate Deposition (CPPD) Disease
- 10:30AM-12:30PM
-
Abstract Number: 0279
Macrophage Intracellular Fates of Monosodium Urate and Calcium Pyrophosphate Crystals: Phagocytosis, Exchanged/expulsion and Dissolution of Crystals
- 10:30AM-12:30PM
-
Abstract Number: 0277
Mesenchymal Stem Cells Derived from Human Bone Marrow Ameliorate Monosodium Urate Crystal-induced Inflammation
- 10:30AM-12:30PM
-
Abstract Number: 0265
Performance of Two Gout Remission Definitions in a Two-Year Randomized Controlled Trial of Nurse-led Care
- 10:30AM-12:30PM
-
Abstract Number: 0283
Prophylaxis of Gout Flares in Patients with Renal Impairment: Dosing Adjustments with Colchicine Oral Solution Informed by a Pharmacokinetic Model
- 10:30AM-12:30PM
-
Abstract Number: 0275
Targeting IRAK4 in Monosodium Urate Crystals Induced Inflammation
- 10:30AM-12:30PM
-
Abstract Number: 0280
Trends in Management and Consultations for Gout: A Study of 18 Million Adults Using the OpenSAFELY Platform
- 10:30AM-12:30PM
-
Abstract Number: 0268
Weight Loss Induced by Anti-obesity Medications and Gout Among Overweight and Obesity Individuals: A Population-based Cohort Study